We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Collaboration to Launch Human Protein Knowledge Platform

By LabMedica International staff writers
Posted on 11 Aug 2011
Print article
An online knowledge platform on human proteins has recently been developed, providing life scientists with a broad spectrum of information on all human proteins.

The SIB Swiss Institute of Bioinformatics (Lausanne) and GeneBio (Geneva, Switzerland) recently announced the launch of the platform called neXtProt. With already over 51,000 unique visitors since its first Beta release in January of 2011, neXtProt is expected to become the central resource for any life scientist who requires high-quality information on human proteins in the context of modern biomedical research.

SIB and GeneBio’s scientists, software developers, and biocurators have been working closely together since 2009 under the leadership of Prof. Amos Bairoch, to address one of the key problems faced by life scientists today: making sense of the huge body of human protein-related data in order to facilitate knowledge creation and scientific innovation. Prof. Bairoch remarked, “Technological advances have allowed life scientists to accumulate enormous amounts of data. It is therefore essential to provide researchers with the tools to fish out knowledge from such an ocean of data. We are building neXtProt to answer such a challenge.”

At the content level, neXtProt aims to be a comprehensive resource on human proteins, including information such as proteins’ function, subcellular location, expression, interactions, and role in diseases. Rigorous standards are applied before any data are added to neXtProt, ensuring a commitment to Swiss quality.

neXtProt builds upon the complete human proteins-related information contained in the UniProtKB/Swiss-Prot knowledgebase, to which unique information relative to protein expression and variants has been integrated by the SIB biocurators. neXtProt provides user-friendly tools to access this unparalleled content. The powerful and intuitive search functionality combined with innovative data representation simplifies data mining. Users can personalize their discoveries of proteins and sets of proteins in context using favorites and tags.

Nasri Nahas, CEO of GeneBio, said, “With second-to-none quality data and a set of intuitive features, we believe that neXtProt will enhance scientific discovery and innovation.”

SIB Swiss Institute of Bioinformatics is an academic not-for-profit foundation that provides bioinformatics activities throughout Switzerland. Its two-fold mission is to provide world-class core bioinformatics resources to the national and international life sciences research community in key fields such as genomics, proteomics and systems biology, as well as to lead and coordinate the field of bioinformatics in Switzerland. The Foundation produces state-of-the-art software for the life sciences research community, as well as carefully annotated databases.

Geneva Bioinformatics (GeneBio) SA is a bioinformatics company providing the life science community with world-class software that bridges the gap between information gathering and knowledge generation. The company offers a suite of software platforms and knowledge bases targeted at small molecules screening and protein research.

Related Links:

SIB Swiss Institute of Bioinformatics
GeneBio
neXtProt


Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Urine Collection Container
Urine Monovette
New
Automated Nucleic Acid Extractor
eLab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.